NYSE:ARMP | Free Cash Flow | Armata Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2013-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$5.78M$63,000.00-$5.85M
2025-12-31-$6.67M$52,000.00-$6.73M
2025-03-31-$7.58M$99,000.00-$7.68M
2024-12-31-$7.93M-$77,000.00-$8M-307.85%
2024-03-31-$10.58M$250,000.00-$10.83M
2023-12-31-$8.11M$2.4M-$10.51M
2023-03-31-$17.57M$2.01M-$19.58M
2022-12-31-$10.49M-$455,000.00-$10.94M
2022-03-31-$3.52M$236,000.00-$3.75M
2021-12-31-$8.6M$228,000.00-$8.83M
2021-03-31-$5.48M$298,000.00-$5.77M
2020-12-31-$6.3M$366,000.00-$6.67M
2020-03-31-$4.23M$104,000.00-$4.34M
2019-12-31-$2.73M$21,000.00-$2.75M
2019-03-31-$2.46M$142,000.00-$2.6M
2018-12-31-$3.2M$391,000.00-$3.59M
2018-03-31-$3.54M
2017-12-31-$2.37M$18,000.00-$2.39M
2017-03-31-$3.3M$5,000.00-$3.3M
2016-12-31-$1.5M$13,000.00-$1.51M
2016-03-31-$3.09M$112,000.00-$3.2M
2015-12-31-$2.32M$50,000.00-$2.37M
2015-03-31-$2.31M$35,000.00-$2.34M
2014-12-31-$3.2M$5,000.00-$3.21M
2014-03-31-$3.69M$229,000.00-$3.92M
2013-12-31-$1.39M$5,000.00-$1.39M
2013-03-31-$1.01M$0.00-$1.01M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$25.76M$542,000.00-$26.31M
2024-12-31-$37.55M$1.88M-$39.43M
2023-12-31-$47.42M$8.14M-$55.57M
2022-12-31-$32.48M$2.21M-$34.69M
2021-12-31-$23.58M$1.3M-$24.88M
2020-12-31-$18.27M$824,000.00-$19.09M
2019-12-31-$15.58M$224,000.00-$15.81M
2018-12-31-$10.63M$875,000.00-$11.5M
2017-12-31-$9.19M$58,000.00-$9.25M
2016-12-31-$10.61M$279,000.00-$10.89M
2015-12-31-$9.78M$210,000.00-$9.99M
2014-12-31-$12.57M$1.2M-$13.77M-59.60%
2013-12-31-$6.29M$102,000.00-$6.39M